Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study

David Zemánek, Josef Veselka(Universitat Autònoma de Barcelona), Pavol Tomašov(Charles University), Marian Branny(Nemocnice Podlesí), Martin Malý(Charles University), David Tesař(Charles University), Lucie Martinkovičová(Charles University), Petr Hájek(University Hospital in Motol)

International Journal of Cardiology

April 17, 2013

10.1016/j.ijcard.2013.03.002

Cited by 19

Related Papers

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

|The Lancet|2020|1.2k

Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest

|JAMA|2022|674

Long‐term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS

|Catheterization and Cardiovascular Interventions|2009|190

Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population

|European Heart Journal|2014|106

A FTO variant and risk of acute coronary syndrome

|Clinica Chimica Acta|2010|65